| Glen D Crawford, MD | |
|
1900 Lafayette Rd, Suite A, Portsmouth, NH 03801-5679 | |
| (603) 431-1121 | |
| (603) 431-9147 |
| Full Name | Glen D Crawford |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 39 Years |
| Location | 1900 Lafayette Rd, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538143482 | NPI | - | NPPES |
| 30004551 | Medicaid | NH | |
| 3072151 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 73568 (Massachusetts) | Secondary |
| 207X00000X | Orthopaedic Surgery | 14791 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| York Hospital | York, ME | Hospital |
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Exeter Hospital Inc | Exeter, NH | Hospital |
| Anna Jaques Hospital | Newburyport, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sportsmedicine Atlantic Orthopaedics Pa | 4587561196 | 22 |
| Sportsmedicine Atlantic Orthopaedics Pa | 4587561196 | 22 |
News Archive
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the establishment of a strategic alliance with Mitsubishi Tanabe Pharma Corporation (MTPC) through the execution of a Master Research Collaboration Agreement.
Johnson & Johnson Medical Devices Companies today announced that Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat technologies, has received clearance from the U.S. Food and Drug Administration to expand the indication for the Acclarent AERA® Eustachian Tube Balloon Dilation System to include its use in patients as young as 18. The device was previously cleared only for adults aged 22 and older.
Medical scientists at the University of Leicester have identified for the first time a new way in which our body controls the levels of sugar in our blood following a meal.
› Verified 5 days ago
| Entity Name | Sportsmedicine Atlantic Orthopaedics Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881631554 PECOS PAC ID: 4587561196 Enrollment ID: O20050518000300 |
News Archive
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the establishment of a strategic alliance with Mitsubishi Tanabe Pharma Corporation (MTPC) through the execution of a Master Research Collaboration Agreement.
Johnson & Johnson Medical Devices Companies today announced that Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat technologies, has received clearance from the U.S. Food and Drug Administration to expand the indication for the Acclarent AERA® Eustachian Tube Balloon Dilation System to include its use in patients as young as 18. The device was previously cleared only for adults aged 22 and older.
Medical scientists at the University of Leicester have identified for the first time a new way in which our body controls the levels of sugar in our blood following a meal.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glen D Crawford, MD 1900 Lafayette Rd, Suite A, Portsmouth, NH 03801-5679 Ph: (603) 431-1121 | Glen D Crawford, MD 1900 Lafayette Rd, Suite A, Portsmouth, NH 03801-5679 Ph: (603) 431-1121 |
News Archive
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the establishment of a strategic alliance with Mitsubishi Tanabe Pharma Corporation (MTPC) through the execution of a Master Research Collaboration Agreement.
Johnson & Johnson Medical Devices Companies today announced that Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat technologies, has received clearance from the U.S. Food and Drug Administration to expand the indication for the Acclarent AERA® Eustachian Tube Balloon Dilation System to include its use in patients as young as 18. The device was previously cleared only for adults aged 22 and older.
Medical scientists at the University of Leicester have identified for the first time a new way in which our body controls the levels of sugar in our blood following a meal.
› Verified 5 days ago
Dr. Frank A Graf, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 10 Vaughan Mall, Ste 207, Portsmouth, NH 03801 Phone: 603-436-5544 Fax: 603-431-3219 | |
Mr. Brian Dennis Barry, PAC Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Lafayette Rd, Suite A, Portsmouth, NH 03801 Phone: 603-431-1121 Fax: 603-431-9147 | |
Ryan Labelle, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Lafayette Rd, Portsmouth, NH 03801 Phone: 603-431-1121 | |
Mr. Barry Christopher Cusson, PA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Lafayette Rd, Suite A, Portsmouth, NH 03801 Phone: 603-431-1121 Fax: 603-431-9147 | |
Dr. Akhilesh Sastry, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Lafayette Rd, Suite A, Portsmouth, NH 03801 Phone: 603-431-1121 Fax: 603-431-9147 | |
Paul J Urbanek, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 67 Corporate Dr Bldg A2nd, Portsmouth, NH 03801 Phone: 603-610-8078 | |
Dr. Thomas Vaill King, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Ave, Medical Office Building Suite 301, Portsmouth, NH 03801 Phone: 603-431-5858 Fax: 603-431-5818 |